Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
This explainer covers the core concept of international dividend ETFs, including structure, distributions, and how they fit portfolios.
10,374 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
This guide walks you through creating a personalized investment strategy that aligns your goals with risk and time. G...
A $50,000 investment can feel like a fork in the road. This guide explains why Amazon stock still has the potential t...
As AI powers a new wave of data centers and resilient grids, bloom energy stock: buy is a topic for thoughtful invest...
Eli Lilly has powered higher for years, delivering eye-popping gains. But is there more room to run, or is it time to...
The battle between FedEx and UPS isn't just about packages—it's about dollars, margins, and future growth. This artic...
Retirees often face market volatility with anxiety. This guide shares actionable steps to protect savings, secure ste...
As AI demand climbs, power reliability becomes the bottleneck. This energy stock helping power AI offers a way to inv...
Two clear reasons reasons give cruise line stocks may rebound as travel demand returns and operators strengthen finan...
A beginner-friendly look at how big investment moves in real estate investment trusts signal risk and income opportun...
May brought a sharp drop in oil markets as prices tumbled nearly 20%. This article breaks down what caused the move, ...
DGRO targets companies with five straight years of dividend growth and a cap on payout ratios, aiming for a rising in...